Neogen® Introduces Igenity® BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk
Rhea-AI Summary
Neogen (NASDAQ: NEOG) has launched Igenity BCHF, a groundbreaking genomic test designed to assess the genetic risk of Bovine Congestive Heart Failure (BCHF) in cattle. The test provides a 1-to-10 scoring system, where 1 indicates the lowest risk and 10 the highest risk of disease development, with each score decrease representing approximately 3.5% lower expected incidence rate.
The innovative test aims to help producers manage BCHF risk within their herds, produce lower-risk feeder calves, and reduce economic losses. BCHF is identified as a significant threat affecting both young calves on pasture and late-fed cattle. According to Dr. Victor Pedrosa, Director of Technical Genomics and Innovation, the test results indicate the percentage of BCHF risk an animal might pass to its progeny.
Positive
- First-of-its-kind genomic test for BCHF risk assessment
- Quantifiable risk assessment with 3.5% reduction per score decrease
- Potential to reduce economic losses from BCHF-related mortality
Negative
- None.
News Market Reaction
On the day this news was published, NEOG gained 1.56%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Bovine Congestive Heart Failure (BCHF) stands as a significant threat to cattle health and productivity, and this genomic test provides a new opportunity for improved selection for heart health. Testing with Igenity BCHF assesses an animal's genetic predisposition for BCHF, scored on a 1-to-10 scale. Ranging from 1 (lowest risk) to 10 (highest risk of disease development), each decreased score on the scale as an approximately
"Igenity BCHF is a revolutionary genomic test designed to assess an animal's genetic predisposition to heart failure," says Victor Pedrosa, Ph.D., Director of Technical Genomics and Innovation at Neogen. "The test results directly correlate with the percentage of BCHF risk an animal carries and could pass on to their progeny, serving as a genetic indicator of the likelihood of disease development."
BCHF presents a growing threat to the health and productivity of all segments of the cattle industry, from young calves on the pasture to late-fed cattle. Igenity BCHF provides producers with the opportunity to more effectively manage the risk of BCHF within their herd, confidently produce feeder calves that will have a lower risk of mortality from BCHF in a feedlot setting, and decrease economic losses attributed to BCHF.
"When we look at the impact of Igenity BCHF on the industry, it is helping to genetically quantify the risk for bovine congestive heart failure and progress herds away from this growing cattle health and welfare concern," says Kirk Ramsey, DVM, Professional Services Veterinarian with Neogen. "Igenity BCHF is the first genomic test of its kind and is the first step in capturing the reason why congestive heart failure is occurring in these young calves and late-fed cattle."
To learn more about Igenity BCHF, visit neogen.com/igenity-beef or contact your Neogen representative.
About Neogen
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
Media Contact
View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-introduces-igenity-bchf-to-help-industry-mitigate-bovine-congestive-heart-failure-risk-302355664.html
SOURCE Neogen Corporation
FAQ
What is the scoring range for Neogen's new Igenity BCHF test?
How does Neogen's Igenity BCHF test benefit cattle producers?
What types of cattle can be affected by BCHF according to NEOG's announcement?
When did Neogen (NEOG) launch the Igenity BCHF test?
